Related references
Note: Only part of the references are listed.A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer Cells
Melissa A. Gray et al.
CHEMBIOCHEM (2016)
Continuous evolution of Bacillus thuringiensis toxins overcomes insect resistance
Ahmed H. Badran et al.
NATURE (2016)
Resurfaced cell-penetrating nanobodies: A potentially general scaffold for intracellularly targeted protein discovery
Virginia J. Bruce et al.
PROTEIN SCIENCE (2016)
Real-time quantification of single RNA translation dynamics in living cells
Tatsuya Morisaki et al.
SCIENCE (2016)
Peptides in headlock - a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy
Michael B. Braun et al.
SCIENTIFIC REPORTS (2016)
Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization
Marta M. Kijanka et al.
EJNMMI RESEARCH (2016)
Came lid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena
Coralie Pain et al.
BIOCHIMIE (2015)
HER2 expression status in diverse cancers: review of results from 37,992 patients
Min Yan et al.
CANCER AND METASTASIS REVIEWS (2015)
Nanobodies and recombinant binders in cell biology
Jonas Helma et al.
JOURNAL OF CELL BIOLOGY (2015)
Crystal structures of a double-barrelled fluoride ion channel
Randy B. Stockbridge et al.
NATURE (2015)
Monobody-mediated alteration of enzyme specificity
Shun-ichi Tanaka et al.
NATURE CHEMICAL BIOLOGY (2015)
Two-sided block of a dual-topology F- channel
Daniel L. Turman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Non-immunoglobulin scaffolds: a focus on their targets
Katja Skrlec et al.
TRENDS IN BIOTECHNOLOGY (2015)
Efficient export of prefolded, disulfide-bonded recombinant proteins to the periplasm by the Tat pathway in Escherichia coli CyDisCo strains
Cristina F. R. O. Matos et al.
BIOTECHNOLOGY PROGRESS (2014)
A Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence Imaging
Marvin E. Tanenbaum et al.
CELL (2014)
Quantitative ImmunoPET of Prostate Cancer Xenografts with 89Zr- and 124I-Labeled Anti-PSCA A11 Minibody
Scott M. Knowles et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin
Tim Eisen et al.
CURRENT ONCOLOGY REPORTS (2014)
Proof of dual-topology architecture of Fluc F- channels with monobody blockers
Randy B. Stockbridge et al.
NATURE COMMUNICATIONS (2014)
IgG subclasses and allotypes: from structure to effector functions
Gestur Vidarsson et al.
FRONTIERS IN IMMUNOLOGY (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody
Marek Pruszynski et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Monoclonal antibody-based therapies in cancer: Advances and challenges
Puja Sapra et al.
PHARMACOLOGY & THERAPEUTICS (2013)
The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of Antibody-Based Drugs
Ruth Muchekehu et al.
TRANSLATIONAL ONCOLOGY (2013)
Genetically encoded system to track histone modification in vivo
Yuko Sato et al.
SCIENTIFIC REPORTS (2013)
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies
Ursula J. E. Seidel et al.
FRONTIERS IN IMMUNOLOGY (2013)
Antibody-Recruiting Molecules: An Emerging Paradigm for Engaging Immune Function in Treating Human Disease
Patrick J. McEnaney et al.
ACS CHEMICAL BIOLOGY (2012)
Preclinical Evaluation of VB6-845: An Anti-EpCAM Immunotoxin with Reduced Immunogenic Potential
Joycelyn Entwistle et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2012)
An Engineered Cysteine-Modified Diabody for Imaging Activated Leukocyte Cell Adhesion Molecule (ALCAM)-Positive Tumors
Katelyn E. McCabe et al.
MOLECULAR IMAGING AND BIOLOGY (2012)
Disulfide bond structures of IgG molecules Structural variations, chemical modifications and possible impacts to stability and biological function
Hongcheng Liu et al.
MABS (2012)
Human Anti-CCR4 Minibody Gene Transfer for the Treatment of Cutaneous T-Cell Lymphoma
Thomas Han et al.
PLOS ONE (2012)
Accuracy and safety of 99mTc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: A phase II study
James D. Douketis et al.
THROMBOSIS RESEARCH (2012)
Evaluation of the Anti-HER2 C6.5 Diabody as a PET Radiotracer to Monitor HER2 status and Predict Response to Trastuzumab Treatment
Smitha Reddy et al.
CLINICAL CANCER RESEARCH (2011)
Non-immunoglobulin based protein scaffolds
John Lofblom et al.
CURRENT OPINION IN BIOTECHNOLOGY (2011)
Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer
Ilse Vaneycken et al.
FASEB JOURNAL (2011)
Analysis and Modeling of the Variable Region of Camelid Single-Domain Antibodies
Aroop Sircar et al.
JOURNAL OF IMMUNOLOGY (2011)
Cystine-knot peptides engineered with specificities for alpha(IIb)beta(3) or alpha(IIb)beta(3) and alpha(v)beta(3) integrins are potent inhibitors of platelet aggregation
Adam P. Silverman et al.
JOURNAL OF MOLECULAR RECOGNITION (2011)
Anti-CA19-9 Diabody as a PET Imaging Probe for Pancreas Cancer
Mark D. Girgis et al.
JOURNAL OF SURGICAL RESEARCH (2011)
A system for the continuous directed evolution of biomolecules
Kevin M. Esvelt et al.
NATURE (2011)
Anti-gp120 Minibody Gene Transfer to Female Genital Epithelial Cells Protects against HIV-1 Virus Challenge In Vitro
Ussama M. Abdel-Motal et al.
PLOS ONE (2011)
An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors
Eric J. Lepin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
Takuo Suzuki et al.
JOURNAL OF IMMUNOLOGY (2010)
Leukemia-specific siRNA delivery by immunonanoplexes consisting of anti-JL1 minibody conjugated to oligo-9 Arg-peptides
Yeon Kyung Lee et al.
MOLECULES AND CELLS (2010)
Antibody fragments Hope and hype
Aaron L. Nelson
MABS (2010)
Modulation of protein properties in living cells using nanobodies
Axel Kirchhofer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Structural and thermodynamic analysis of the GFP:GFP-nanobody complex
Marta H. Kubala et al.
PROTEIN SCIENCE (2010)
Challenges in monoclonal antibody-based therapies
Haritha Samaranayake et al.
ANNALS OF MEDICINE (2009)
Applications of single-chain variable fragment antibodies in therapeutics and diagnostics
Nina E. Weisser et al.
BIOTECHNOLOGY ADVANCES (2009)
Engineered protein scaffolds as next-generation antibody therapeutics
Michaela Gebauer et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
An Antibody-Recruiting Small Molecule That Targets HIV gp120
Christopher G. Parker et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Development trends for therapeutic antibody fragments
Aaron L. Nelson et al.
NATURE BIOTECHNOLOGY (2009)
Neonatal Fc Receptor Mediates Internalization of Fc in Transfected Human Endothelial Cells
Nancy A. Goebl et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Targeting and tracing antigens in live cells with fluorescent nanobodies
Ulrich Rothbauer et al.
NATURE METHODS (2006)
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
E De Genst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Engineering novel binding proteins from nonimmunoglobulin domains
HK Binz et al.
NATURE BIOTECHNOLOGY (2005)
Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy
C Ebbinghaus et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Engineered antibody fragments and the rise of single domains
P Holliger et al.
NATURE BIOTECHNOLOGY (2005)
A single treatment of yttrium-90-labeled CHX-A-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice
GP Adams et al.
CANCER RESEARCH (2004)
Bispecific minibodies targeting HER2/neu and CD16 exhibit improved tumor lysis when placed in a divalent tumor antigen binding format
LS Shahied et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications
T Olafsen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Single-domain antibody fragments with high conformational stability
M Dumoulin et al.
PROTEIN SCIENCE (2002)
The structure of a human type III Fcγ receptor in complex with Fc
S Radaev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Advances in immunology: Complement (First of two parts).
MJ Walport
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Design and application of diabodies, triabodies and tetrabodies for cancer targeting
A Todorovska et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Share Paper
